Basis of Presentation and Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Schedule of Reconciliation of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the unaudited condensed consolidated statements of cash flows that sum to the total of the same such amounts shown in the unaudited condensed consolidated statements of cash flows (in thousands):

	March 31, 2024				March 31, 2023
	Beginning of period		End of period		Beginning of period		End of period
Cash and cash equivalents	$	188,657	$	204,745	$	114,846	$	290,895
Restricted cash		5,770		5,770		5,770		5,770
Total cash, cash equivalents and restricted cash shown in    the unaudited condensed consolidated statements of cash flows	$	194,427	$	210,515	$	120,616	$	296,665

Schedule of revenue consist of product sales to customers

The Company operates in one business segment. Results of its operations are reported on a consolidated basis for purposes of segment reporting, consistent with internal management reporting. Revenues consist of net product sales to customers, all of which are sales in the U.S. Revenues by product are as follows (in thousands):

	Three Months Ended March 31,
	2024		2023
NUPLAZID	$	129,923	$	118,462
DAYBUE	$	75,908		—
Product sales, net	$	205,831	$	118,462